SCHEMBL5377683

SCHEMBL5377683

NC(=O)c1cc2[nH]c(N3CCC(Cc4ccccc4)CC3)nc2cc1Cl

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
HTR2B P41595 1/20 0.45
MAPK14 Q16539 1/20 0.45
GAA P10253 1/20 0.44
PRCP P42785 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
GRIN1 Q05586 2/20 0.43
GRIN2B Q13224 2/20 0.43
GRIN2D O15399 1/20 0.43
GRIN3B O60391 1/20 0.43
GRIN2A Q12879 1/20 0.43
GRIN2C Q14957 1/20 0.43
GRIN3A Q8TCU5 1/20 0.43
MAPT P10636 1/20 0.43
ALDH1A1 P00352 1/20 0.43
SLC6A9 P48067 1/20 0.42
GPR84 Q9NQS5 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5377680 0.96 CYP2C9 (0.45) CYP2C9CYP2C19HTR2BMAPK14GAA
SCHEMBL5374168 0.86 MEN1 (0.55) CYP2C9CYP2C19MAPK14MEN1KMT2A
SCHEMBL5374164 0.84 MEN1 (0.55) CYP2C9CYP2C19MAPK14MEN1KMT2A
SCHEMBL5387265 0.83 GPR84 (0.52) CYP2C9CYP2C19HTR2BMAPK14GAA
SCHEMBL5372873 0.83 CHEK2 (0.57) GAAGRIN1GRIN2B
SCHEMBL5372866 0.83 GAA (0.52) GAAMEN1KMT2AGRIN1GRIN2B
SCHEMBL5374207 0.81 GPR84 (0.52) CYP2C9CYP2C19HTR2BMAPK14GAA
SCHEMBL4436265 0.76 GRIN2B (0.65) GRIN1GRIN2BGRIN2AGRIN2CMAPT
SCHEMBL19058671 0.75 HDAC6 (0.62) GRIN1GRIN2B
SCHEMBL4427814 0.75 MEN1 (0.55) GAAMEN1KMT2AGRIN1GRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7189739-B2 Compounds and methods to treat cardiac failure and other disorders SCIOS, INC. (US) 2007-03-13 US disclosed
EP-1080078-B1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC (US) 2006-02-01 EP disclosed
US-6589954-B1 Indoles, benzimidazoles and benztriazoles which are substituted at the 5 or 6 position with a substituent comprising an aromatic moiety linked through a piperazine ring to said indole, benzimidazole or benztriazole are useful SCIOS, INC. 2003-07-08 US disclosed
EP-1080078-A1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC. (US) 2001-03-07 EP disclosed
WO-1999061426-A1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC. (US) 1999-12-02 WO disclosed